224 related articles for article (PubMed ID: 18086758)
1. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
Auranen A; Song H; Waterfall C; Dicioccio RA; Kuschel B; Kjaer SK; Hogdall E; Hogdall C; Stratton J; Whittemore AS; Easton DF; Ponder BA; Novik KL; Dunning AM; Gayther S; Pharoah PD
Int J Cancer; 2005 Nov; 117(4):611-8. PubMed ID: 15924337
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes.
Nagle CM; Chenevix-Trench G; Webb PM; Spurdle AB
Cancer Lett; 2007 Jun; 251(1):96-104. PubMed ID: 17182175
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PD; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; Vandenberg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM; ; ;
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3567-72. PubMed ID: 19064572
[TBL] [Abstract][Full Text] [Related]
5. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
6. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mędrek K; Lubiński J; Ness RB; Moysich KB; Lurie G; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; ; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PD; Gayther SA; Ramus SJ;
Int J Cancer; 2011 May; 128(9):2063-74. PubMed ID: 20635389
[TBL] [Abstract][Full Text] [Related]
7. Consortium analysis of 7 candidate SNPs for ovarian cancer.
Ramus SJ; Vierkant RA; Johnatty SE; Pike MC; Van Den Berg DJ; Wu AH; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA; DiCioccio RA; McGuire V; Whittemore AS; Song H; Easton DF; Pharoah PDP; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Terry KL; Cramer DW; Tworoger SS; Hankinson SE; Berchuck A; Moorman PG; Schildkraut JM; Cunningham JM; Liebow M; Kjaer SK; Hogdall E; Hogdall C; Blaakaer J; Ness RB; Moysich KB; Edwards RP; Carney ME; Lurie G; Goodman MT; Wang-Gohrke S; Kropp S; Chang-Claude J; Webb PM; Chen X; Beesley J; Chenevix-Trench G; Goode EL
Int J Cancer; 2008 Jul; 123(2):380-388. PubMed ID: 18431743
[TBL] [Abstract][Full Text] [Related]
8. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract][Full Text] [Related]
9. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
10. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
Gayther SA; Song H; Ramus SJ; Kjaer SK; Whittemore AS; Quaye L; Tyrer J; Shadforth D; Hogdall E; Hogdall C; Blaeker J; DiCioccio R; McGuire V; Webb PM; Beesley J; Green AC; Whiteman DC; ; Goodman MT; Lurie G; Carney ME; Modugno F; Ness RB; Edwards RP; Moysich KB; Goode EL; Couch FJ; Cunningham JM; Sellers TA; Wu AH; Pike MC; Iversen ES; Marks JR; Garcia-Closas M; Brinton L; Lissowska J; Peplonska B; Easton DF; Jacobs I; Ponder BA; Schildkraut J; Pearce CL; Chenevix-Trench G; Berchuck A; Pharoah PD;
Cancer Res; 2007 Apr; 67(7):3027-35. PubMed ID: 17409409
[TBL] [Abstract][Full Text] [Related]
11. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
13. RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.
Kelemen L; Spurdle AB; Purdie DM; Gertig D; Chenevix-Trench G
Cancer Lett; 2005 Feb; 218(2):191-7. PubMed ID: 15670896
[TBL] [Abstract][Full Text] [Related]
14. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of 17 β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias.
Sata F; Kurahashi N; Ban S; Moriya K; Tanaka KD; Ishizuka M; Nakao H; Yahata Y; Imai H; Kakizaki H; Nonomura K; Kishi R
J Sex Med; 2010 Aug; 7(8):2729-38. PubMed ID: 20059664
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.
Bouanene H; Hadj Kacem H; Ben Fatma L; Ben Limem H; Ben Ahmed S; Yakoub S; Miled A
Pathol Oncol Res; 2011 Jun; 17(2):295-9. PubMed ID: 21046495
[TBL] [Abstract][Full Text] [Related]
19. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.
Li Q; Zhu Y; He J; Wang M; Zhu M; Shi T; Qiu L; Ye D; Wei Q
Mol Biol Rep; 2013 May; 40(5):3597-608. PubMed ID: 23277398
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
Amankwah EK; Wang Q; Schildkraut JM; Tsai YY; Ramus SJ; Fridley BL; Beesley J; Johnatty SE; Webb PM; Chenevix-Trench G; ; Dale LC; Lambrechts D; Amant F; Despierre E; Vergote I; Gayther SA; Gentry-Maharaj A; Menon U; Chang-Claude J; Wang-Gohrke S; Anton-Culver H; Ziogas A; Dörk T; Dürst M; Antonenkova N; Bogdanova N; Brown R; Flanagan JM; Kaye SB; Paul J; Bützow R; Nevanlinna H; Campbell I; Eccles DM; Karlan BY; Gross J; Walsh C; Pharoah PD; Song H; Krüger Kjær S; Høgdall E; Høgdall C; Lundvall L; Nedergaard L; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Le ND; Brooks-Wilson A; Cook LS; Phelan CM; Cunningham JM; Vachon CM; Vierkant RA; Iversen ES; Berchuck A; Goode EL; Sellers TA; Kelemen LE
PLoS One; 2011; 6(5):e19642. PubMed ID: 21637745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
